Cargando…

Decremental responses in patients with motor neuron disease

OBJECTIVE: Involvement of the neuromuscular junction (NMJ) in amyotrophic lateral sclerosis (ALS) has been reported and is increasingly recognized as an important pathophysiological aspect. The relationship between decrement and clinical measures for possible application as a biomarker has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanazy, Mohammed H., Hegedus, Janka, White, Chris, Korngut, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698864/
https://www.ncbi.nlm.nih.gov/pubmed/29201547
http://dx.doi.org/10.1002/brb3.846
_version_ 1783280840146419712
author Alanazy, Mohammed H.
Hegedus, Janka
White, Chris
Korngut, Lawrence
author_facet Alanazy, Mohammed H.
Hegedus, Janka
White, Chris
Korngut, Lawrence
author_sort Alanazy, Mohammed H.
collection PubMed
description OBJECTIVE: Involvement of the neuromuscular junction (NMJ) in amyotrophic lateral sclerosis (ALS) has been reported and is increasingly recognized as an important pathophysiological aspect. The relationship between decrement and clinical measures for possible application as a biomarker has not been comprehensively explored. METHODS: We performed routine repetitive nerve stimulation (RNS) of three nerves on patients with ALS. We captured measures of muscle strength, grip strength, fatigability, and calculated slow vital capacity (SVC) rates of change assessing for associations. RESULTS: In 42 subjects, 210 muscles were studied. Negative correlation was found between the percentage of decrement and compound muscle action potential (CMAP) amplitude. Approximately half of the patients with hand weakness did not have decrement. There was no significant correlation between decrement and handgrip fatigue, SVC < 80% predicted, or more rapid worsening of SVC over time. CONCLUSIONS: Abnormal decremental responses are well described in ALS. We report that the degree of decremental response does not correlate with the degree of weakness. Abnormal decrement is only rarely present in nerve–muscle pairs with normal motor power. Our findings did not support a correlation between abnormal decrement and clinical measures suggesting that RNS may not be useful as a biomarker to monitor ALS progression.
format Online
Article
Text
id pubmed-5698864
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56988642017-11-30 Decremental responses in patients with motor neuron disease Alanazy, Mohammed H. Hegedus, Janka White, Chris Korngut, Lawrence Brain Behav Original Research OBJECTIVE: Involvement of the neuromuscular junction (NMJ) in amyotrophic lateral sclerosis (ALS) has been reported and is increasingly recognized as an important pathophysiological aspect. The relationship between decrement and clinical measures for possible application as a biomarker has not been comprehensively explored. METHODS: We performed routine repetitive nerve stimulation (RNS) of three nerves on patients with ALS. We captured measures of muscle strength, grip strength, fatigability, and calculated slow vital capacity (SVC) rates of change assessing for associations. RESULTS: In 42 subjects, 210 muscles were studied. Negative correlation was found between the percentage of decrement and compound muscle action potential (CMAP) amplitude. Approximately half of the patients with hand weakness did not have decrement. There was no significant correlation between decrement and handgrip fatigue, SVC < 80% predicted, or more rapid worsening of SVC over time. CONCLUSIONS: Abnormal decremental responses are well described in ALS. We report that the degree of decremental response does not correlate with the degree of weakness. Abnormal decrement is only rarely present in nerve–muscle pairs with normal motor power. Our findings did not support a correlation between abnormal decrement and clinical measures suggesting that RNS may not be useful as a biomarker to monitor ALS progression. John Wiley and Sons Inc. 2017-09-26 /pmc/articles/PMC5698864/ /pubmed/29201547 http://dx.doi.org/10.1002/brb3.846 Text en © 2017 The Authors. Brain and Behavior published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Alanazy, Mohammed H.
Hegedus, Janka
White, Chris
Korngut, Lawrence
Decremental responses in patients with motor neuron disease
title Decremental responses in patients with motor neuron disease
title_full Decremental responses in patients with motor neuron disease
title_fullStr Decremental responses in patients with motor neuron disease
title_full_unstemmed Decremental responses in patients with motor neuron disease
title_short Decremental responses in patients with motor neuron disease
title_sort decremental responses in patients with motor neuron disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698864/
https://www.ncbi.nlm.nih.gov/pubmed/29201547
http://dx.doi.org/10.1002/brb3.846
work_keys_str_mv AT alanazymohammedh decrementalresponsesinpatientswithmotorneurondisease
AT hegedusjanka decrementalresponsesinpatientswithmotorneurondisease
AT whitechris decrementalresponsesinpatientswithmotorneurondisease
AT korngutlawrence decrementalresponsesinpatientswithmotorneurondisease